CD38-specific nanobodies allow
CD38
daratumumab
flow cytometry
fluorescence imaging
multiple myeloma
nanobody
Journal
Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960
Informations de publication
Date de publication:
2022
2022
Historique:
received:
02
08
2022
accepted:
03
10
2022
entrez:
17
11
2022
pubmed:
18
11
2022
medline:
22
11
2022
Statut:
epublish
Résumé
Recent studies have demonstrated the feasibility of CD38-specific antibody constructs for We conjugated the CD38-specific nanobody JK36 to the near-infrared fluorescent dye Alexa Fluor 680. The capacity of JK36 Fluorochrome-labeled nanobody JK36 Our study demonstrates that a nanobody recognizing a distinct, non-overlapping epitope of CD38 allows the specific detection of myeloma cells under daratumumab therapy
Identifiants
pubmed: 36389758
doi: 10.3389/fimmu.2022.1010270
pmc: PMC9647632
doi:
Substances chimiques
daratumumab
4Z63YK6E0E
Single-Domain Antibodies
0
ADP-ribosyl Cyclase 1
EC 3.2.2.6
Fluorescent Dyes
0
Epitopes
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1010270Informations de copyright
Copyright © 2022 Pape, Hambach, Gebhardt, Rissiek, Stähler, Tode, Khan, Weisel, Adam, Koch-Nolte and Bannas.
Déclaration de conflit d'intérêts
FK-N receives a share of antibody sales via MediGate GmbH, a wholly-owned subsidiary of the University Medical Center Hamburg-Eppendorf. PB and FK-N are co-inventors on a patent application on CD38-specific nanobodies. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Eur J Nucl Med Mol Imaging. 2021 Aug;48(9):2749-2760
pubmed: 33543326
J Hematol Oncol. 2021 Nov 2;14(1):183
pubmed: 34727950
Int J Cancer. 2002 Mar 20;98(3):456-62
pubmed: 11920600
Lancet. 2016 Apr 9;387(10027):1551-1560
pubmed: 26778538
Eur Radiol. 2012 Sep;22(9):2007-12
pubmed: 22544292
Radiology. 2020 Jun;295(3):606-615
pubmed: 32255416
Mol Imaging. 2008 Jan-Feb;7(1):21-7
pubmed: 18384720
J Clin Oncol. 2013 Jul 10;31(20):2540-7
pubmed: 23733781
Sci Transl Med. 2016 Nov 23;8(366):366ra162
pubmed: 27881823
Front Immunol. 2018 Nov 06;9:2559
pubmed: 30459772
Front Immunol. 2021 Mar 09;12:632687
pubmed: 33767701
Cytometry B Clin Cytom. 2016 Jan;90(1):91-100
pubmed: 26130131
Mol Imaging Biol. 2021 Apr;23(2):186-195
pubmed: 32964391
Biochem Biophys Res Commun. 2021 Jan 15;536:26-31
pubmed: 33360095
Am J Clin Pathol. 2022 Apr 1;157(4):494-497
pubmed: 34643211
Lancet Oncol. 2014 Nov;15(12):e538-48
pubmed: 25439696
N Engl J Med. 2016 Aug 25;375(8):754-66
pubmed: 27557302
Contrast Media Mol Imaging. 2015 Sep-Oct;10(5):367-78
pubmed: 25925493
Contrast Media Mol Imaging. 2014 Mar-Apr;9(2):135-42
pubmed: 24523058
Molecules. 2012 May 10;17(5):5564-91
pubmed: 22576228
Med Microbiol Immunol. 2009 Aug;198(3):157-74
pubmed: 19529959
Clin Chem Lab Med. 2016 Jun 1;54(6):1105-9
pubmed: 26812873
Front Immunol. 2018 Nov 19;9:2553
pubmed: 30524421
Haematologica. 2017 Sep;102(9):e368-e370
pubmed: 28522580
J Vis Exp. 2015 Apr 06;(98):e52462
pubmed: 25867711
Cells. 2020 Jan 29;9(2):
pubmed: 32013131
World J Orthop. 2014 Jul 18;5(3):272-82
pubmed: 25035830
N Engl J Med. 2019 May 30;380(22):2104-2115
pubmed: 31141632
Cancer. 2019 Jul 15;125(14):2364-2382
pubmed: 30951198
Front Immunol. 2022 May 16;13:838406
pubmed: 35651607
Cancers (Basel). 2020 Dec 30;13(1):
pubmed: 33396591
Annu Rev Biochem. 2013;82:775-97
pubmed: 23495938
Lancet Haematol. 2020 Jun;7(6):e447-e455
pubmed: 32470437
Blood Adv. 2020 Oct 27;4(20):5194-5202
pubmed: 33095874
Am J Clin Pathol. 2020 Jan 2;153(2):221-228
pubmed: 31679012
Eur Radiol. 2013 Feb;23(2):570-8
pubmed: 22843058
Front Immunol. 2021 Sep 03;12:703574
pubmed: 34539634
Ann Oncol. 2021 Mar;32(3):309-322
pubmed: 33549387
Gene Ther. 2010 Apr;17(4):511-20
pubmed: 20016542
Eur J Nucl Med Mol Imaging. 2018 Jul;45(8):1372-1381
pubmed: 29450576
Eur J Nucl Med Mol Imaging. 2022 Apr;49(5):1470-1481
pubmed: 34677626
Rofo. 2019 Nov;191(11):998-1009
pubmed: 31137045
Protein Expr Purif. 2009 May;65(1):77-82
pubmed: 19007889
Int J Hematol. 2019 Sep;110(3):322-330
pubmed: 31183814
Cell Immunol. 2005 Jul-Aug;236(1-2):66-71
pubmed: 16271711
Theranostics. 2020 Feb 3;10(6):2645-2658
pubmed: 32194826
Sci Rep. 2017 Oct 30;7(1):14289
pubmed: 29084989
JAMA Oncol. 2018 Sep 1;4(9):1221-1227
pubmed: 29800065
Am J Clin Pathol. 2021 Jul 6;156(2):198-204
pubmed: 33437993
Blood. 2016 Jul 21;128(3):384-94
pubmed: 27222480
Clin Biochem. 2016 Oct;49(15):1202-1204
pubmed: 27475249
Blood Adv. 2022 Aug 05;:
pubmed: 35930694